BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS
Cedars-Sinai Medical Center
Los Ángeles, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Cedars-Sinai Medical Center (1)
2018
-
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study
The Lancet Oncology, Vol. 19, Núm. 3, pp. 370-381